Ionis presents positive Phase 2 data in patients with IgA Nephropathy at American Society of Nephrology's Kidney Week 2022

/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today presented positive results from a Phase 2 clinical study of IONIS-FB-LRx in patients with...

Related Keywords

United States ,American ,Richard Geary ,Exchange Commission ,Prnewswire Ionis Pharmaceuticals Inc ,Twitter ,American Society Of Nephrology ,Ionis Pharmaceuticals Inc ,Ionis Pharmaceuticals ,Nasdaq ,American Society ,Kidney Week ,Alternative Pathway Activity ,Iga Nephropathy ,Nc ,